CC
The Chemours Company
Basic Materials · Chemicals - Specialty
Undervalued·Quality 55·RSI 64·DCF -73%·Conviction 70
Investment Thesis — The Chemours Company
The market is fixated on Chemours' unsustainable dividend yield and recent negative EPS, leading to an overly pessimistic valuation and high short interest. This misprices the underlying business's potential for a cyclical recovery and the necessary, value-unlocking financial restructuring implied by its positive forward earnings projections.
Catalysts
- Formal announcement of a sustainable dividend policy, removing uncertainty and freeing capital.
- Stronger-than-expected earnings reports demonstrating positive EPS and improving margins.
- Evidence of a broad cyclical recovery in basic materials demand and pricing power.
Risk Factors
- Deeper or prolonged cyclical downturn impacting demand and pricing across key segments.
- Failure to achieve projected profitability, leading to continued negative EPS and cash flow issues.
- Significant legal or environmental liabilities, common in the chemicals industry, impacting financials.
Key Debates
D/E ratio falls below 10 by Q4, restoring positive ROE.
Gross margin expands to 20%+ by Q3, driving net profitability.
P/S multiple re-rates to 0.7x by Q1 2025 on improved earnings outlook.